Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Schmidt, K L JuliëtteDautzenberg, Noël M M
Hoogerbrugge, Peter M
Lindemans, Caroline A
Nierkens, Stefan
Smits, Gaby
Van Binnendijk, Rob S
Bont, Louis J
Tissing, Wim J E
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.Published in
Cancers 2023;15(9):2562PMID
37174028ae974a485f413a2113503eed53cd6c53
10.3390/cancers15092562
Scopus Count
Collections
Related articles
- Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination.
- Authors: Sisteré-Oró M, Wortmann DDJ, Andrade N, Aguilar A, Mayo de Las Casas C, Casabal FG, Torres S, Bona Salinas E, Raventos Soler L, Arcas A, Esparre C, Garcia B, Valarezo J, Rosell R, Güerri-Fernandez R, Gonzalez-Cao M, Meyerhans A
- Issue date: 2022
- T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients.
- Authors: Delrue L, Muylaert A, Beernaert A, De Pelsmaeker I, Boel E, Moya A, Verstreken S, Dierckx R, Heggermont W, Bartunek J, Vanderheyden M
- Issue date: 2022 Sep 3
- Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.
- Authors: Hollstein MM, Münsterkötter L, Schön MP, Bergmann A, Husar TM, Abratis A, Eidizadeh A, Schaffrinski M, Zachmann K, Schmitz A, Holsapple JS, Stanisz-Bogeski H, Schanz J, Fischer A, Groß U, Leha A, Zautner AE, Schnelle M, Erpenbeck L
- Issue date: 2022 Aug
- mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
- Authors: Oosting SF, van der Veldt AAM, GeurtsvanKessel CH, Fehrmann RSN, van Binnendijk RS, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, Bhattacharya A, van der Heiden M, Rimmelzwaan GF, Kvistborg P, Blank CU, Koopmans MPG, Huckriede ALW, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE
- Issue date: 2021 Dec
- Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
- Authors: Vinh DC, Gouin JP, Cruz-Santiago D, Canac-Marquis M, Bernier S, Bobeuf F, Sengupta A, Brassard JP, Guerra A, Dziarmaga R, Perez A, Sun Y, Li Y, Roussel L, Langelier MJ, Ke D, Arnold C, Whelan M, Pelchat M, Langlois MA, Zhang X, Mazer BD, COVID-19 Immunity Task Force and UNCoVER Investigators
- Issue date: 2022 Mar